Green Medical, Inc.

National University of Ireland, Galway

Tulip Endovascular Innovation Limited

Embricon Limited

Sherif Sultan

Edward George Mackay, Ii

Alan A Creamer

Killian O'Dowd

Anthony Jakubowski

Aidan Mulloy

Niamh Hynes

Colm Anthony McCormack

Robert Miculas

Stefan Lohfeld

Colin Henehan

Aldan Mulloy

Marto Hoary

The present invention provides a percutaneous vascular surgical system for performing endovascular/neurovascular interventions, the system incorporating a sheath having a proximal end and a distal end and defining a main lumen extending between the proximal and distal ends, an auxiliary lumen also defined by the sheath, a reversibly inflatable balloon located about the sheath adjacent the distal end and in fluid communication with the auxiliary lumen, a syringe selectively connectable to the main lumen to create suction through the main lumen, and a vessel closure device for the closure of the arteriotomy, the surgical system and method of the invention having utility in a large number of percutaneous vascular procedures such as carotid artery stenosis or neurovascular interventions and enabling four procedures to be performed with one system, being percutaneous access, emboli removal, flow reversal and arteriotomy closure.

Percutaneous vascular surgical system and method

A delivery system for delivery of a therapeutic agent such as stem cells into a vein and across a micro circulation system into an artery comprises a multi lumen catheter for delivery of a therapeutic agent. A discharge device is located in a vein. The operation of the delivery device is controlled by a pressure stem cell solution delivery gun system. There are multiple delivery stages. These may include delivery of an elixir to open up the pressure bed, a platelet-rich plasma, stem cells, scaffolds, and finally an elixir to provide emichment and nourishment of the stem cells.

Therapeutic agent delivery system and method for arteries

Systems and methods treat superficial venous malformations, such as spider veins. The systems and methods distribute a light-reactive agent, e.g., verteporfin, at or near an inner wall of a vein. The systems and methods activate the light-reactive agent by applying non-thermal light energy at a wavelength that activates the light-reactive agent to cause localize injury to the inner wall of the vein.

Systems and methods for treating superficial venous malformations like spider veins

Systems and methods treat superficial venous malformations, such as spider veins. The systems and methods distribute a reactive agent, e.g., a light-reactive agent such as talaporfin sodium or verteporfin, at or near an inner wall of a vein. The systems and methods activate the reactive agent by applying energy, e.g. non-thermal light energy at a wavelength that activates the reactive agent to cause localized injury to the inner wall of the vein.

A vein stripping deviceincludes a catheterfor insertion into a veinto be removed. The catheterhas a proximal regionadjacent a proximal endof the catheterand a distal regionadjacent a distal endof the catheter. The catheteris open at the distal end for passage of blood through the catheter from the distal end. The catheterhas a plurality of vein grippersat least along the distal regionfor gripping a length of the veinto the catheter. The vein grippers include a plurality of holes and/or gripping featuresspaced-apart along the wall of the catheter

Vein stripping device

Growing community of inventors

Galway, Ireland

Sherif Sultan